By implementation of the anti-Hyp564 antibody, D’Angelo et al. were capable of detecting hydroxylated ODD-GFP but not HIF-1α species in C6 glioma normoxic cells, which indirectly indicated that the former had longer half-lives [88]. This evidence concerns the gene HIF1A and central nervous system cancer.